Table 1 Description of the Kenyan Kawasaki disease cases from AKUHN and GCH
From: Kawasaki disease in Kenya and review of the African literature
| Â | AKUHN | GCH | TOTAL |
|---|---|---|---|
n (%) | |||
No. of cases | 15 (65) | 8 (35) | 23 (100) |
Age [mean+/-SD, range, years] | 2+/-1.5 [0.3–5.7] | 3+/-3.2 [0.7–10.3] | 2.3+/-2.2 [0.3–10.3] |
Sex - Males | 8 (53.3) | 4 (50) | 12 (52.2) |
Duration of fever at diagnosis [mean+/-SD, range, days] | 6.8+/-3.4 [2–13] | 11.3+/-5.3 [5–20] | 8.3+/-4.7 [2–20] |
Incomplete KD | 7 (46.7) | 5 (62.5) | 12 (52.2) |
Clinical Features | |||
Fever | 15 (100) | 8 (100) | 23 (100) |
Oral Changes | 15 (100) | 8 (100) | 22 (95.7) |
Rash | 13 (86.7) | 7 (87.5) | 20 (87) |
Extremity changes | 12 (80) | 6 (75) | 18 (78.3) |
Cervical lymphadenopathy | 9 (60) | 3 (37.5) | 12 (52.2) |
Nonexudative conjunctivitis | 8 (53.3) | 3 (37.5) | 11 (47.8) |
Laboratory Investigations | |||
CRP (> 5 mg/ L) | 12/12 (100) | 8/8 (100) | 20/20 (100) |
Erythrocyte Sedimentation Rate (> 15 mm/hr) | 8/9 (88.9) | 5/5 (100) | 13/14 (92.9) |
Platelets (≥ 450*109) | 8/15 (53.3) | 4/8 (50) | 12 (52.2) |
Treatment | |||
IVIG | 14 (93.3) | 7 (87.5) | 21 (91.3) |
Aspirin | 14 (93.3) | 8 (100) | 22 (95.7) |
Corticosteroids | 2 (13.3) | 2 (25) | 4 (17.4) |
Echocardiogram | |||
Number of Baseline Echocardiograms | 14 (93.3) | 8 (100) | 22 (95.7) |
Number of Baseline Echocardiograms with CAA | 1/14 (7.1) | 1/8 (12.5) | 2/22 (9.1) |